Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
therapeutics entities : Global blood therapeutics, inc. save search
Aligos Therapeutics Strengthens Finance Leadership Team with Two New Appointments
Published: 2024-02-13 (Crawled : 13:00) - globenewswire.com
CWBR | $0.9003 360
|
Health Technology
|
| O: 6.09%
H: 0.0%
C: -17.23%
CDNA | $8.105 0.43% 130K
|
Health Technology
|
| O: -7.39%
H: 2.74%
C: -5.24%
ALGS | $0.761 -4.05% 39K
|
Health Technology
|
| O: 1.47%
H: 1.45%
C: -7.54%
therapeutics
Sickle Cell Disease Clinical Trial Pipeline Accelerates as 40+ Pharma Companies Rigorously Developing Drugs for the Market Entry
Published: 2023-07-11 (Crawled : 21:00) - prnewswire.com
DTIL | $9.985 -6.86% 93K
|
Health Technology
|
| O: 1.57%
H: 19.67%
C: 9.97%
BLUE | $0.9812 2.96% 4.3M
|
Health Technology
|
| O: 2.2%
H: 0.27%
C: -1.62%
BLRX | $0.6401 42K
|
Health Technology
|
| O: 0.0%
H: 2.94%
C: -0.59%
pharma disease companies pipeline cell trial market
Sickle Cell Disease Market to Observe Impressive Growth, Predicts DelveInsight | Key Companies Active in the Domain - Sanofi, Novartis, Vertex, CRISPR, Vifor, Pfizer, GlaxoSmithKline, Alexion, Global Blood
Published: 2023-05-22 (Crawled : 15:00) - prnewswire.com
VRTX | News | $395.0 0.39% 550K
|
Health Technology
|
| O: 0.69%
H: 0.56%
C: -1.19%
SNY | News | $46.545 2.55% 2.3M
|
Health Technology
|
| O: -0.75%
H: 0.0%
C: 0.0%
EDIT | $5.43 -2.16% 770K
|
Health Technology
|
| O: -0.97%
H: 4.98%
C: 4.44%
BEAM | $24.42 0.45% 440K
|
Health Technology
|
| O: 0.2%
H: 2.51%
C: 1.56%
AGIO | News | $29.65 0.75% 350K
|
Health Technology
|
| O: 0.38%
H: 2.48%
C: 1.87%
disease companies active cell blood global market
Tarsus Appoints Jeff Farrow as Chief Financial Officer and Chief Strategy Officer
Published: 2023-04-24 (Crawled : 13:00) - biospace.com/
TARS | $32.89 0.12% 200K
|
Health Technology
|
| O: -1.47%
H: 0.75%
C: -0.75%
financial
ElevateBio Appoints Heidi L. Wagner, J.D., as Global Head of Government Affairs
Published: 2023-03-07 (Crawled : 14:00) - biospace.com/
GBT | $68.49 0.02% -0.02%
|
Health Technology
| Email alert
Add to watchlist
global
PFIZER REPORTS RECORD FULL-YEAR 2022 RESULTS AND PROVIDES FULL-YEAR 2023 FINANCIAL GUIDANCE
Published: 2023-01-31 (Crawled : 13:00) - biospace.com/
GLAXF | $20.2 510
|
Health Technology
|
| O: 2.04%
H: 0.0%
C: -3.67%
PFE A | $25.81 1.65% 15M
|
Health Technology
|
| O: -1.26%
H: 2.97%
C: 2.7%
GSK | $39.605 0.85% 790K
|
Health Technology
|
| O: 0.85%
H: 0.31%
C: -0.45%
BHVN | News 0 d | $39.335 -6.7% 1.2M
|
Health Technology
|
| O: -0.48%
H: 4.49%
C: 3.24%
BNTX | $86.81 0.74% 230K
|
Health Technology
|
| O: -1.74%
H: 4.84%
C: 3.88%
BEAM | $24.42 0.45% 440K
|
Health Technology
|
| O: 0.21%
H: 4.84%
C: 2.99%
financial results
LAMEA Attention Deficit Hyperactivity Disorder Market 2022: Sector to Grow by 7.3% Annually Through 2028
Published: 2023-01-18 (Crawled : 12:00) - prnewswire.com
MNK | $0.3402 -0.06% 540K
|
n/a
|
| O: -0.13%
H: 3.25%
C: -3.0%
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: 0.05%
H: 0.0%
C: 0.0%
TAK | News | $13.185 0.19% 430K
|
Health Technology
|
| O: 0.62%
H: 0.12%
C: -0.68%
PFE A | $25.81 1.65% 15M
|
Health Technology
|
| O: -1.16%
H: 0.67%
C: -1.2%
NVS | $93.81 1.34% 1.2M
|
Health Technology
|
| O: 0.93%
H: 0.01%
C: -1.16%
JNJ | News | $147.17 0.98% 3.2M
|
Health Technology
|
| O: -0.41%
H: 0.2%
C: -1.1%
LLY | $728.765 -2.3% 1.5M
|
Health Technology
|
| O: -0.4%
H: 0.75%
C: -1.21%
SUPN | $29.28 1.42% 100K
|
Health Technology
|
| O: 0.07%
H: 2.69%
C: 0.32%
market
Global Hemoglobinopathies Market Report 2022: Rising Cases in Under-Developed Countries Boosts Growth
Published: 2023-01-16 (Crawled : 14:00) - prnewswire.com
ALNY | News | $145.89 0.5% 170K
|
Health Technology
| Email alert
Add to watchlist
PFE A | $25.81 1.65% 15M
|
Health Technology
| Email alert
Add to watchlist
SNYNF | News | $92.7 600K
|
Health Technology
| Email alert
Add to watchlist
EMMA | $0.1138 300
|
Professional, Scientific, and T...
| Email alert
Add to watchlist
ABT | News | $106.76 1.42% 3.8M
|
Health Technology
| Email alert
Add to watchlist
DHR | $235.02 -0.57% 750K
|
Health Technology
| Email alert
Add to watchlist
GBT | $68.49 0.02% -0.02%
|
Health Technology
| Email alert
Add to watchlist
SNY | News | $46.545 2.55% 2.3M
|
Health Technology
| Email alert
Add to watchlist
global report growth market
Global Hemoglobinopathies Market Report to 2031 - Featuring Abbott Laboratories, Alnylam Pharmaceuticals, Biogen Idec and Bluebird Among Others
Published: 2022-11-21 (Crawled : 16:00) - prnewswire.com
EMMA | $0.1138 300
|
Professional, Scientific, and T...
|
| O: 33.02%
H: 0.0%
C: -21.11%
ARVL | News | $0.49 0.37% 2.5M
|
Manufacturing
|
| O: -5.8%
H: 0.0%
C: 0.0%
NVS | $93.81 1.34% 1.2M
|
Health Technology
|
| O: 0.74%
H: 0.89%
C: 0.53%
DHR | $235.02 -0.57% 750K
|
Health Technology
|
| O: -0.32%
H: 1.21%
C: 0.09%
ABT | News | $106.76 1.42% 3.8M
|
Health Technology
|
| O: -0.13%
H: 1.13%
C: 0.14%
SNY | News | $46.545 2.55% 2.3M
|
Health Technology
|
| O: 1.02%
H: 0.0%
C: 0.0%
SGMO | $0.5225 7.71% 500K
|
Health Technology
|
| O: -1.1%
H: 1.66%
C: -0.28%
ALNY | News | $145.89 0.5% 170K
|
Health Technology
|
| O: 0.22%
H: 2.19%
C: -5.13%
global report market
Syros Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides a Corporate Update
Published: 2022-11-14 (Crawled : 13:20) - biospace.com/
SYRS | $4.525 -4.13% 50K
|
Health Technology
|
| O: -1.76%
H: 2.56%
C: -6.39%
pharmaceuticals financial update results
Sickle Cell Disease Treatment Market to Garner USD 1.6 Billion by 2031: Allied Market Research
Published: 2022-11-10 (Crawled : 01:00) - prnewswire.com
EMMA | $0.1138 300
|
Professional, Scientific, and T...
|
| O: -18.92%
H: 15.0%
C: 15.0%
NVS | $93.81 1.34% 1.2M
|
Health Technology
|
| O: 2.81%
H: 0.43%
C: -0.2%
treatment research disease market
Pfizer Reports Strong Third-quarter 2022 Results and Raises 2022 Outlook
Published: 2022-11-01 (Crawled : 12:00) - biospace.com/
HLN | $8.205 0.92% 2M
|
n/a
|
| O: 0.16%
H: 1.79%
C: 0.16%
GLAXF | $20.2 510
|
Health Technology
|
| O: -1.68%
H: 0.0%
C: -0.27%
SNYNF | News | $92.7 600K
|
Health Technology
|
| O: 7.74%
H: 0.17%
C: 0.17%
PFE A | $25.81 1.65% 15M
|
Health Technology
|
| O: 3.11%
H: 0.88%
C: 0.02%
GSK | $39.605 0.85% 790K
|
Health Technology
|
| O: 1.72%
H: 0.39%
C: -0.83%
BHVN | News 0 d | $39.335 -6.7% 1.2M
|
Health Technology
|
| O: 1.81%
H: 3.08%
C: -0.65%
SNY | News | $46.545 2.55% 2.3M
|
Health Technology
|
| O: 0.23%
H: 0.0%
C: 0.0%
BNTX | $86.81 0.74% 230K
|
Health Technology
|
| O: 4.54%
H: 4.25%
C: 0.13%
BEAM | $24.42 0.45% 440K
|
Health Technology
|
| O: 3.25%
H: 1.41%
C: -2.48%
ARVN | $34.02 -0.79% 250K
|
Health Technology
|
| O: 1.49%
H: 3.25%
C: 1.68%
results
Pfizer Completes Acquisition of Global Blood Therapeutics
Published: 2022-10-05 (Crawled : 16:00) - biospace.com/
PFE A | $25.81 1.65% 15M
|
Health Technology
|
| O: -0.76%
H: 0.57%
C: 0.0%
acquisition blood global therapeutics
STOCKHOLDER ALERT: The M&A Class Action Firm Launches Merger Inquiry - RFP, SBTX, GBT, EVOP
Published: 2022-09-24 (Crawled : 20:20) - prnewswire.com
GPN | $122.43 0.21% 250K
|
Technology Services
| Email alert
Add to watchlist
EVOP 4 | $33.99 0.38% 0.38% 0
|
Commercial Services
| Email alert
Add to watchlist
RFP | $21.92 0.0% 0
|
Process Industries
| Email alert
Add to watchlist
GBT | $68.49 0.02% -0.02%
|
Health Technology
| Email alert
Add to watchlist
Folia Health Technology Platform Used in First-of-its-Kind Real World Evidence Study for Sickle Cell Disease
Published: 2022-09-15 (Crawled : 23:00) - biospace.com/
GBT | $68.49 0.02% -0.02%
|
Health Technology
|
| O: -0.15%
H: 0.06%
C: -0.1%
disease health technology study platform
GBT Supports the Sickle Cell Disease Treatment Centers Act of 2022
Published: 2022-09-15 (Crawled : 23:00) - globenewswire.com
GBT | $68.49 0.02% -0.02%
|
Health Technology
|
| O: -0.1%
H: 0.1%
C: -0.13%
treatment disease
Pfizer to Acquire Global Blood Therapeutics for $5.4 Billion to Enhance Presence in Rare Hematology
Published: 2022-08-08 (Crawled : 11:00) - globenewswire.com
PFE A | $25.81 1.65% 15M
|
Health Technology
|
| O: 0.24%
H: 0.85%
C: 0.36%
MS | News 0 d | $91.34 1.2% 2.9M
|
Finance
|
| O: 0.73%
H: 0.53%
C: -0.84%
GBT | $68.49 0.02% -0.02%
|
Health Technology
|
| O: 41.47%
H: 0.0%
C: 0.0%
blood rare global acquire therapeutics
GBT to Announce Second Quarter 2022 Financial Results on Monday, August 8, 2022
Published: 2022-07-29 (Crawled : 13:00) - biospace.com/
GBT | $68.49 0.02% -0.02%
|
Health Technology
|
| O: -4.73%
H: 1.17%
C: 0.89%
results
MHRA Grants Marketing Authorization for GBT’s Oxbryta® (voxelotor) for Use in Great Britain for the Treatment of Hemolytic Anemia in Patients with Sickle Cell Disease Age 12 Years and Older
Published: 2022-07-26 (Crawled : 08:00) - globenewswire.com
GBT | $68.49 0.02% -0.02%
|
Health Technology
|
| O: -0.42%
H: 1.7%
C: -0.33%
oxbryta treatment disease anemia grants authorization
GBT Initiates Expanded Access Program for Voxelotor in Patients With Sickle Cell Disease in Brazil
Published: 2022-07-14 (Crawled : 14:20) - biospace.com/
GBT | $68.49 0.02% -0.02%
|
Health Technology
|
| O: -0.65%
H: 0.15%
C: -1.05%
disease brazil program
Gainers vs Losers
| 73% | 27% |
Top 10 Gainers
AGBA | News | $1.27 217.5% 120M
|
Finance
EGOX | $0.054 50.0% 290M
|
RWOD | $10.52 31.56% 5.9M
|
n/a
NVFY | $2.71 28.44% 31M
|
Consumer Durables
ZCMD | $1.86 28.28% 29M
|
Commercial Services
MRDB 4 | $0.536 27.65% 2M
|
n/a
BSFC | $0.0822 27.64% 75M
|
Manufacturing
INDO | $5.1 25.0% 15M
|
Energy Minerals
CHRO | $1.53 24.9% 100K
|
n/a
GBR | $1.33 23.15% 560K
|
Energy Minerals
Your saved searches
Save your searches and get alerts when important news are released.